P04578 (ENV_HV1H2) Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1)

Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling

856 aa; Sequence (Fasta)

Available Structures

128 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Model of gp120, including variable regions, in complex with CD4 and 17b Heteromer
P01730;
31-500
100
Crystal structure of llama VHH antibody in complex with HIV-1 HXBC2 gp120 core Heteromer
45-491
100.0NAG;
Crystal Structure of FH1 Fab bound to HXb2 HIV-1 gp120 core Heteromer
47-492
97.4NAG;NAG;NH4;EDO;SO4;
HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B Heteromer
P01730;
83-492
97.83NAG; 12×NAG;IPA;
HIV-1 gp120 Envelope Glycoprotein Complexed with the Broadly Neutralizing CD4-Binding-Site Antibody… Heteromer
P01834;
83-492
92.1113×NAG;
Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C222 Heteromer
83-492
91.316×NAG;EPE;SO4;GOL;
Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C2221 Heteromer
83-492
91.328×NAG;SO4;
HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY Heteromer
P01730;
90-492
100NAG;NAG;
Molecular structure for the HIV-1 gp120 trimer in the CD4-bound state Heteromer
90-492
100
Molecular structure for the HIV-1 gp120 trimer in the unliganded state Heteromer
90-492
100
Molecular structure for the HIV-1 gp120 trimer in the b12-bound state Heteromer
90-492
100
Crystal structure of anti-HIV llama VHH antibody J3 in complex with HIV-1 C1086 gp120 Heteromer
C6G099;
45-397
100NAG;SO4;
Crystal structure of anti-HIV llama VHH antibody A12 in complex with HIV-1 C1086 gp120 Heteromer
C6G099;
45-397
100NAG;
HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B Heteromer
P01730;
195-492
100NAG; 12×NAG;IPA;
Crystal structure of asymmetric HIV-1 gp41 containing all membrane anchors Heteromer
518-706
98.63
Crystal Structure at 4.3 A Resolution of Glycosylated HIV-1 Clade A BG505 SOSIP.664 Prefusion Env T… Heteromer
P01857; P0DOY2; Q2N0S6;
518-664
79.84NAG;NAG;NAG; 24×NAG;NAG;NAG;NAG; 18×NAG;SO4;
Crystal structure of the germline-targeting HIV-1 gp120 engineered outer domain eOD-GT6 in complex … Heteromer
254-396
84.09NAG;
Structure of T20/N39 Heteromer
536-670
100
Crystal structure of broad and potent HIV-1 neutralizing antibody PGT128 in complex with a glycosyl… Heteromer
P01857; P0DOY2; Q75760;
275-396
90.32NAG;NAG;
crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix Heteromer
543-662
100
Structure of C34M/N36 Heteromer
546-661
100
Structure of C34N126K/N36 Heteromer
546-661
100
Structure of C34E136G/N36 Heteromer
546-661
100
HIV GP41 CORE STRUCTURE Heteromer
546-661
100
A new HIV fusion peptide inhibitor Heteromer
546-661
100
Gp41-targeting HIV-1 fusion inhibitors with hook-like Ile-Asp-Leu tail Heteromer
539-653
100.0TAM;
Crystal structure of C14linkmid/IQN17: a cross-linked inhibitor of HIV-1 entry bound to the gp41 hy… Heteromer
P03069;
566-639
100CL;N2P;
Structure of HP101/N44 Heteromer
538-581
100
Crystal structure of LP-46/N44 Heteromer
538-581
100
Artificial HIV fusion inhibitor AP3 fused to the C-terminus of gp41 NHR Heteromer
548-590
100SO4;EDO;P4G;
Crystal structure of HIV-1 fusion inhibitor MT-WQ-IDL bound to gp41 NHR Heteromer
538-580
100
Crystal structure of HIV-1 fusion inhibitor SC29EK complexed with gp41 NHR (N44) Heteromer
540-581
100
crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide Heteromer
671-709
97.44NAG;PC;
HIV-gp41 fusion inhibitor Sifuvirtide Heteromer
546-581
100
Crystal structure of HIV-1 fusion inhibitor SC29EK complexed with gp41 NHR (N36) Heteromer
546-581
100
Crystal structure of HP23L/N36 Heteromer
546-581
100
Crystal structure of HP23LN36KR Heteromer
546-581
94.44
Crystal structure of LP-11/N44 Heteromer
546-581
100
Crystal Structure of a Generation 3 Influenza Hemagglutinin Stabilized Stem Complexed with the Broa… Heteromer
D9IEJ2; Q6WG00;
546-577
100.0NAG;NAG;
Crystal structure of a generation 4 influenza hemagglutinin stabilized stem in complex with the bro… Heteromer
Q6WG00;
546-577
100.0
Crystal structure of DH1346 Fab in complex with HIV proximal MPER peptide Heteromer
P0DOX5;
655-683
93.1NA;F;
THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR IN COMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE Heteromer
P03069; P03377;
636-663
100
Crystal structure of broad neutralizing antibody 10E8 with long epitope bound Heteromer
669-689
100PO4;
Crystal structure of Fab460 in complex with MPER peptide Heteromer
658-677
85.0
Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a gp41 MPER-derived … Heteromer
Q8TCD0; S6B291;
653-671
100EDO;
crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide Heteromer
671-689
94.74NAG;DPV;
crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide Heteromer
671-689
94.74NAG;PO4;PC;
PIE12 D-PEPTIDE AGAINST HIV ENTRY (IN COMPLEX WITH IQN17 Q577R RESISTANCE MUTANT) Heteromer
P03069;
566-581
93.75CL;
Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a gp41 MPER-derived … Heteromer
Q8TCD0; S6B291;
656-671
93.75NA;
Crystal structure of DH1322.1 Fab in complex with HIV proximal MPER peptide Heteromer
655-670
100NAG;NAG;
Crystal structure of Fab235 in complex with MPER peptide Heteromer
668-683
100GOL;
Crystal structure of 10E8v4-5R+100cF Fab in complex with HIV-1 gp41 peptide Heteromer
668-683
87.5
Crystal structure of the F240 antibody fragment bound to the HIV-1 gp41 immunodominant region Heteromer
596-610
86.67GOL;ACT;
Llama VHH 2E7 in complex with gp41 Heteromer
582-596
100
Crystal structure of DH1317.8 Fab in complex with HIV proximal MPER peptide Heteromer
655-668
100NAG;
Crystal structure of 4E10 modified with pyrene acetamide Heteromer
671-683
92.31GOL;ACT;
Crystal structure of broadly neutralizing anti-HIV-1 antibody 4E10, mutant Npro, with peptide bound Heteromer
671-683
92.31GOL;PGE;P6G;CL;ACT;
Anti-HIV-1 broadly neutralizing antibody delta-loop 4E10 modified with pyrene acetamide Heteromer
671-683
92.31SO4;NH4;GOL;CL;
Crystal Structure of non-neutralizing version of 4E10 (DeltaLoop) with epitope bound Heteromer
671-683
92.31GOL;CL;
High-resolution crystal structure of ERAP1 in complex with 15mer phosphinic peptide Heteromer
Q9NZ08;
308-320
100.0NAG;ZN;B3P; 21×EDO;NA;PPI;NAG;
Crystal Structure of non-neutralizing version of 4E10 (WDWD) with epitope bound Heteromer
671-683
92.31GOL;CL;ACT;
Crystal structure of the Fab fragment of the human HIV-1 neutralizing antibody PGZL1.H4K3 in comple… Heteromer
671-683
92.31GOL;PO4;
Crystal structure of the germline PGZL1 (PGZL1_gVmDmJ) Fab in complex with MPER peptide epitope. Heteromer
671-683
92.31GOL;SO4;
Crystal structure of the Fab fragment of the human HIV-1 neutralizing antibody PGZL1 in complex wit… Heteromer
671-683
92.3144E;
Crystal structure of the Fab fragment of the human HIV-1 neutralizing antibody PGZL1 in complex wit… Heteromer
671-683
92.31GOL;SO4;
Crystal structure of the 3D6 antibody fragment bound to the HIV-1 gp41 immunodominant region Heteromer
600-610
90.91
Fab/epitope complex structure of rabbit monoclonal antibody R53 targeting an epitope in HIV-1 gp120… Heteromer
431-441
90.91
Crystal structures in an anti-HIV antibody lineage from immunization of Rhesus macaques Heteromer
660-670
100
STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS Heteromer
P01834; S6B291;
596-606
100
Crystal Structure of HLA-B*57:01 with a modified HIV peptide RKV-Kyn Heteromer
P01889; P61769;
2-11
100.0ACT;
Crystal Structure of HLA-B*57:01 with an HIV peptide RKV Heteromer
P01889; P61771;
2-11
100.0
Crystal Structure of B4.2.3 T-Cell Receptor and H2-Dd P18-I10 Complex Heteromer
P01887; P01900;
311-320
100EDO;
Crystal structure of H-2Dd with C84-C139 disulfide in complex with gp120 derived peptide P18-I10 Heteromer
P01900; P61769;
311-320
100
Crystal structure of Fab.34.5.8 in complex with MHC-I (H2-Dd) Heteromer
P01887; P01900;
311-320
100GOL;EDO;
Crystal structure of Fab.34.2.12 in complex with MHC-I (H2-Dd) Heteromer
P01887; P01900;
311-320
100EDO;GOL;
Crystal structure of Fab.S19.8 in complex with MHC-I (H2-Dd) Heteromer
P01887; P01900;
311-320
100SO4;GOL;
Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Pept… Heteromer
Q8NF17;
660-668
100
Crystal structure of HIV-1 broadly neutralizing antibody ACS202 Heteromer
512-520
88.89SO4;
N123-VRC34_pI4 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519 Heteromer
Q6GMX0;
512-519
87.5
N123-VRC34_pI3 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519 Heteromer
Q6GMX0;
512-519
87.5
Structure of mouse vaccination-elicited HIV neutralizing antibody vFP5.01 in complex with HIV-1 fus… Heteromer
512-519
87.5
Vaccine-elicited murine FP-targeting antibody vFP25.18 in complex with HIV fusion peptide (residue … Heteromer
512-519
87.5
Vaccine-elicited NHP FP-targeting antibody DF2F-e.01 in complex with HIV fusion peptide (residue 51… Heteromer
512-519
87.5
Vaccine-elicited NHP FP-targeting neutralizing antibody DF2F-b.04 in complex with HIV fusion peptid… Heteromer
512-519
87.5
Vaccine-elicited NHP FP-targeting antibody 0PV-a.04 in complex with HIV fusion peptide (residue 512… Heteromer
512-519
87.5SO4;
N123-VRC34.05 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519 Heteromer
P0DOX5; Q6GMX0;
512-519
87.5
Vaccine-elicited NHP FP-targeting antibody 13N024-a.01 in complex with HIV fusion peptide (residue … Heteromer
512-519
87.5
Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-c.01 in complex with FP (residue 512-51… Heteromer
512-519
87.5
Vaccine-elicited NHP FP-targeting antibody DF2F-a.01 in complex with HIV fusion peptide (residue 51… Heteromer
512-519
87.5
Vaccine-elicited murine FP-targeting antibody vFP6.01 in complex with HIV fusion peptide (residue 5… Heteromer
512-519
87.5
Structure of vaccine-elicited diverse HIV-1 neutralizing antibody vFP1.01 in complex with HIV-1 fus… Heteromer
512-519
87.5SO4;
Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-b.01 in complex with HIV fusion peptide… Heteromer
512-519
87.5
Vaccine-elicited NHP FP-targeting neutralizing antibody 0PV-a.01 in complex with FP (residue 512-51… Heteromer
512-519
87.5SO4;CA;
Vaccine-elicited NHP FP-targeting HIV neutralizing antibody DFPH-a.15 in complex with HIV fusion pe… Heteromer
512-519
87.5
Vaccine-elicited NHP FP-targeting neutralizing antibody A12V163-a.02 in complex with HIV fusion pep… Heteromer
512-519
87.5
Vaccine-elicited mouse FP-targeting neutralizing antibody vFP16.02 with S48K mutation in light chai… Heteromer
512-519
87.5
Vaccine-elicited NHP FP-targeting HIV neutralizing antibody A12V163-a.01 in complex with HIV fusion… Heteromer
512-518
85.71
Vaccine-elicited NHP FP-targeting neutralizing antibody DF1W-a.01 in complex with HIV fusion peptid… Heteromer
512-518
85.71
Crystal structure of the HIV-1 Cross Neutralizing Antibody 2F5 in complex with gp41 Peptide ELLELDK… Heteromer
Q6PYX1;
661-667
100
Model of the HIV-1 gp41 membrane-proximal external region, transmembrane domain and cytoplasmic tailhomo-3-mer660-856
94.29
Structure of the HIV-1 gp41 transmembrane domain and cytoplasmic tailhomo-3-mer677-856
94.3
Model of the HIV-1 gp41 membrane-proximal external region, transmembrane domain and cytoplasmic tai…homo-3-mer660-788
92.52
HIV-1 gp41 variant V549E resistance mutationhomo-3-mer543-661
97.3
HIV-1 gp41 variant Q552R and L555M resistance mutationshomo-3-mer543-661
94.87
Structure of the HIV-1 gp41 transmembrane domain and cytoplasmic tail (LLP2)homo-3-mer677-788
92.22
INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSIONhomo-3-mer546-655
100
Crystal structure analysis of the gp41 core mutanthomo-3-mer546-653
100.0
Gp41-targeting HIV-1 fusion inhibitors with helical Ile-Asp-Leu tailhomo-3-mer546-653
100.0
Crystal structure analysis of gp41 core mutanthomo-3-mer547-653
100.0
HELICAL INTERACTIONS IN THE HIV-1 GP41 CORE REVEALS STRUCTURAL BASIS FOR THE INHIBITORY ACTIVITY OF…homo-3-mer547-653
100
INTERACTIONS BETWEEN HIV-1 GP41 CORE AND DETERGENTS AND THEIR IMPLICATIONS FOR MEMBRANE FUSIONhomo-3-mer548-651
100.0
HIV-1 gp41 coiled-coil pocket IQN22homo-3-mer540-586
55.32
HIV-1 gp41 coiled-coil pocket IQN17homo-3-mer540-581
50.0ACY;CL;
Oligomeric Structure of the HIV gp41 MPER-TMD in Phospholipid Bilayershomo-3-mer665-703
100
Artificial HIV fusion inhibitor AP1 fused to the C-terminus of gp41 NHRhomo-3-mer546-582
97.3GOL;
Artificial HIV fusion inhibitor AP2 fused to the C-terminus of gp41 NHRhomo-3-mer548-582
97.14MG;PEG;
NMR assignment and structure of a peptide derived from the fusion peptide of HIV-1 gp41 in the pres…monomer514-671
100
NMR assignment and structure of a peptide derived from the fusion peptide of HIV-1 gp41 in the pres…monomer514-671
100
Crystal structure of the germline-targeting HIV-1 gp120 engineered outer domain, eOD-GT6monomer254-397
84.09NAG;
HIV-1 gp41 clade B double alanine mutant Membrane Proximal External Region peptide in DPC micellemonomer657-683
92.59
NMR assignment and structure of a peptide derived from the membrane proximal external region of HIV…monomer671-693
95.65
NMR assignment and structure of a peptide derived from the membrane proximal external region of HIV…monomer671-693
95.65
NMR assignment and structure of a peptide derived from the trans-membrane region of HIV-1 gp41 in t…monomer683-704
100
HIV-1 gp41 Membrane Proximal Ectodomain Region peptide in DPC micellemonomer662-683
100
NMR assignment and structure of a peptide derived from the membrane proximal external region of HIV…monomer671-690
95.0
NMR assignment and structure of a peptide derived from the fusion peptide of HIV-1 gp41 in the pres…monomer655-671
100
Solution ensemble structures of HIV-1 gp41 2F5 mAb epitopemonomer659-671
100
Solution NMR Structure of Unbound P18-I10monomer311-320
100

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8eu8.1.Ahomo-3-mer0.6634-664
NAG;75.32
7n6u.1.Ahomo-3-mer0.5631-663
NAG;83G;89.85